Willberg B, Müller E
Department of Pediatric Surgery, University of Düsseldorf, FRG.
Prog Pediatr Surg. 1991;26:76-83. doi: 10.1007/978-3-642-88324-8_9.
Nesidioblastosis is a life-threatening form of hypoglycemia that starts during the neonatal period in most cases and is caused by hyperinsulinism. Its diagnostic criteria are an extremely high demand for carbohydrates (more than 15 g/kg/day), an inadequately high plasma insulin level, and an inhibited production of ketone bodies. This acute, life-threatening hypoglycemia requires immediate intensive-care treatment. The most important aim of continuous therapy is the prevention of irreversible brain damage. This cannot be reliably avoided by conservative treatment (increased carbohydrate supply, diazoxide administration). Therefore, surgical treatment consisting in subtotal pancreatectomy is becoming increasingly important. The reduction of hormone-producing tissue resolves hyperinsulinism and apparently enables the onset of physiological regulatory mechanisms. Surgical strategy and results in 12 children who underwent surgery for nesidioblastosis are described.
成胰岛细胞增殖症是一种危及生命的低血糖症,多数情况下始于新生儿期,由高胰岛素血症引起。其诊断标准为对碳水化合物的极高需求量(超过15克/千克/天)、血浆胰岛素水平过高且酮体生成受抑制。这种急性、危及生命的低血糖症需要立即进行重症监护治疗。持续治疗的最重要目标是预防不可逆的脑损伤。保守治疗(增加碳水化合物供应、使用二氮嗪)无法可靠地避免这种情况。因此,包括胰腺次全切除术在内的手术治疗变得越来越重要。减少产生激素的组织可解决高胰岛素血症问题,并显然能启动生理调节机制。本文描述了12例因成胰岛细胞增殖症接受手术的儿童的手术策略及结果。